Your search history is turned on.
Date: April 29, 2024 Jurisdictions: Alberta, British Columbia, Ontario
CAN: 51027655.3 FORM 51-102F3 MATERIAL CHANGE REPORT 1. Name and Address of Company Lobe Sciences Ltd. (the "Company" or "Lobe") Suite 1400-1199 West Hastings Street Vancouver, BC V6E 3T2 2. Date of Material Change April 4, 2024 3. News Release A news release disclosing the material change was disseminated thro...
Press Release Lobe Sciences Announces Completion of Milestones and Issuance of Shares for Acquisition of Altemia April 29, 2024 -- Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases, is pleased to announce that the Company issu...
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Mathew Lee, Chief Financial Officer of Lobe Sciences Ltd., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Lobe Sciences Ltd. (the issuer) for the interim period ended February 29, 2024...
_ 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Philip J. Young, Chief Executive Officer of Lobe Sciences Ltd., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Lobe Sciences Ltd. (the issuer) for the interim period ended February...
Greenstone - Financial Statements - Prelim (01549002.DOCX;2) LOBE SCIENCES LTD. Condensed Interim Consolidated Financial Statements For the three months and six months ended February 29, 2024 and February 28, 2023 (Unaudited - Expressed in Canadian dollars) Notice of Dis...
LOBE SCIENCES LTD. Managements Discussion & Analysis For the three months and six months ended February 29, 2024 and February 28, 2023 (Expressed in Canadian dollars) LOBE SCIENCES LTD. Managements Discussion & Analysis For the three and six months ended February 29, 2024 and February 28, 2023 (Expressed i...
Date: February 20, 2024 Jurisdictions: Alberta, British Columbia, Ontario
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Mathew Lee, Chief Financial Officer of Lobe Sciences Ltd., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Lobe Sciences Ltd. (the issuer) for the interim period ended November 30, 2023...
_ 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Philip J. Young, Chief Executive Officer of Lobe Sciences Ltd., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Lobe Sciences Ltd. (the issuer) for the interim period ended November...
LOBE SCIENCES LTD. Managements Discussion & Analysis For the three months ended November 30, 2023 and 2022 (Expressed in Canadian dollars) LOBE SCIENCES LTD. Managements Discussion & Analysis For the three months ended November 30, 2023 and 2022 (Expressed in Canadian dollars, except where noted) ...
Greenstone - Financial Statements - Prelim (01549002.DOCX;2) LOBE SCIENCES LTD. Condensed Interim Consolidated Financial Statements For the three months ended November 30, 2023 and 2022 (Unaudited - Expressed in Canadian dollars) Notice of Disclosure of Non-audit...